|
US2859239A
(en)
*
|
1956-08-17 |
1958-11-04 |
Dow Chemical Co |
Acrylic acid compounds
|
|
CH549339A
(de)
|
1971-05-12 |
1974-05-31 |
Ciba Geigy Ag |
Herbizides mittel.
|
|
US5763647A
(en)
*
|
1990-03-30 |
1998-06-09 |
Shionogi & Co., Ltd. |
Preparation of optically active 1,4-bridged-cyclohexane carboxylic acid derivatives
|
|
CA2072270A1
(en)
*
|
1991-06-26 |
1992-12-27 |
Joseph V. Koleske |
Production of unsaturated cycloaliphatic esters and derivatives thereof
|
|
WO1999031073A1
(en)
|
1997-12-15 |
1999-06-24 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel pyrimidine-5-carboxamide derivatives
|
|
JP2002523497A
(ja)
|
1998-08-29 |
2002-07-30 |
アストラゼネカ・アクチエボラーグ |
ピリミジン化合物
|
|
US6797706B1
(en)
|
1999-06-09 |
2004-09-28 |
Yamanouchi Pharmaceutical Co., Ltd. |
Heterocyclecarboxamide derivative
|
|
AU5108000A
(en)
|
1999-06-10 |
2001-01-02 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel nitrogen-contaiing heterocyclic derivatives or salts thereof
|
|
WO2001000213A1
(en)
|
1999-06-30 |
2001-01-04 |
Merck & Co., Inc. |
Src kinase inhibitor compounds
|
|
CN1222520C
(zh)
|
1999-08-12 |
2005-10-12 |
沃泰克斯药物股份有限公司 |
c－JUN N－末端激酶(JNK)和其它蛋白激酶的抑制剂
|
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
|
GB0206215D0
(en)
|
2002-03-15 |
2002-05-01 |
Novartis Ag |
Organic compounds
|
|
JPWO2003082855A1
(ja)
|
2002-03-28 |
2005-08-04 |
協和醗酵工業株式会社 |
抗炎症剤
|
|
US7449456B2
(en)
|
2002-06-28 |
2008-11-11 |
Astellas Pharma, Inc. |
Diaminopyrimidinecarboxamide derivative
|
|
BR0313059B8
(pt)
|
2002-07-29 |
2021-07-27 |
Rigel Pharmaceuticals |
composto, e, composição farmacêutica
|
|
JPWO2004054617A1
(ja)
|
2002-12-13 |
2006-04-20 |
協和醗酵工業株式会社 |
中枢疾患の予防および／または治療剤
|
|
JP4392661B2
(ja)
*
|
2003-01-16 |
2010-01-06 |
東レ・ファインケミカル株式会社 |
光学活性ジアシル酒石酸の回収方法
|
|
WO2004065378A1
(en)
|
2003-01-17 |
2004-08-05 |
Warner-Lambert Company Llc |
2-aminopyridine substituted heterocycles as inhibitors of cellular proliferation
|
|
EP1590334B1
(en)
|
2003-01-30 |
2009-08-19 |
Boehringer Ingelheim Pharmaceuticals Inc. |
2,4-diaminopyrimidine derivatives useful as inhibitors of pkc-theta
|
|
SI2287156T1
(sl)
|
2003-08-15 |
2013-09-30 |
Novartis Ag |
2,4-di(fenilamino)-pirimidini, uporabni pri zdravljenju neoplastičnih bolezni, vnetnih motenj in motenj imunskega sistema
|
|
CN1871009A
(zh)
|
2003-09-24 |
2006-11-29 |
惠氏控股公司 |
作为抗癌剂的5－芳基嘧啶
|
|
WO2005095382A1
(ja)
|
2004-03-30 |
2005-10-13 |
Kyowa Hakko Kogyo Co., Ltd. |
抗腫瘍剤
|
|
JP2008505910A
(ja)
|
2004-07-08 |
2008-02-28 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
Ｐｋｃ−シータのインヒビターとして有用なピリミジン誘導体
|
|
WO2006027377A1
(en)
|
2004-09-10 |
2006-03-16 |
Altana Pharma Ag |
Ciclesonide and syk inhibitor combination and methods of use thereof
|
|
EP1791538A1
(en)
|
2004-09-10 |
2007-06-06 |
Altana Pharma AG |
Roflumilast and syk inhibitor combination and methods of use thereof
|
|
JP2006124387A
(ja)
|
2004-09-30 |
2006-05-18 |
Taisho Pharmaceut Co Ltd |
新規なキノリン、テトラヒドロキナゾリン、及びピリミジン誘導体と、これらを使用することに関連した治療方法
|
|
RU2410379C2
(ru)
|
2004-09-30 |
2011-01-27 |
Тиботек Фармасьютикалз Лтд. |
5-замещенные пиримидины, ингибирующие вич
|
|
WO2006091737A1
(en)
|
2005-02-24 |
2006-08-31 |
Kemia, Inc. |
Modulators of gsk-3 activity
|
|
US20110098301A1
(en)
|
2005-03-10 |
2011-04-28 |
Bayer Healthcare Llc |
Pyrimidine Derivatives for Treatment of Hyperproliferative Disorders
|
|
WO2007032445A1
(ja)
|
2005-09-16 |
2007-03-22 |
Kyowa Hakko Kogyo Co., Ltd. |
タンパク質キナーゼ阻害剤
|
|
JP2009544592A
(ja)
|
2006-07-21 |
2009-12-17 |
ノバルティス アクチエンゲゼルシャフト |
Ｊａｋキナーゼ阻害剤としての２，４−ジ（アリールアミノ）−ピリミジン−５−カルボキサミド化合物
|
|
US8188113B2
(en)
|
2006-09-14 |
2012-05-29 |
Deciphera Pharmaceuticals, Inc. |
Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
|
US20080139531A1
(en)
|
2006-12-04 |
2008-06-12 |
Alcon Manufacturing Ltd. |
Use of connective tissue mast cell stabilizers to facilitate ocular surface re-epithelization and wound repair
|
|
CL2007003693A1
(es)
*
|
2006-12-22 |
2008-06-27 |
Actelion Pharmaceuticals Ltd |
Compuestos derivados de pirido [3,2-b] [1,4] tiazina; composicion farmaceutica que contiene dichos compuestos; y su uso en el tratamiento de infecciones bacterianas.
|
|
JP4782239B2
(ja)
|
2007-04-18 |
2011-09-28 |
ファイザー・プロダクツ・インク |
異常細胞増殖治療のためのスルホニルアミド誘導体
|
|
CA2687943A1
(en)
|
2007-04-27 |
2008-11-06 |
Astrazeneca Ab |
N'-(phenyl)-n-(morpholin-4-yl-pyridin-2-yl)-pyrimidine-2,4-diamine derivatives as ephb4 kinase inhibitors for the treatment of proliferative conditions
|
|
BRPI0814821A2
(pt)
|
2007-07-16 |
2015-02-03 |
Astrazeneca Ab |
Composto, composição farmacêutica, e, processo para preparar um composto
|
|
BRPI0814432A2
(pt)
|
2007-07-17 |
2017-05-09 |
Rigel Pharmaceuticals Inc |
pirimidinadiaminas substituídas por amina cíclica como inibidores de pkc
|
|
JP5269444B2
(ja)
*
|
2008-03-11 |
2013-08-21 |
東ソー・ファインケム株式会社 |
固体ルイス酸触媒、それを用いたディールスアルダー付加物の製造方法
|
|
CA2960692C
(en)
|
2008-04-16 |
2019-09-24 |
Portola Pharmaceuticals, Inc. |
2,6-diamino-pyrimidin-5-yl-carboxamides as syk or jak kinase inhibitors
|
|
SG2014015085A
(en)
|
2008-04-16 |
2014-06-27 |
Portola Pharm Inc |
2,6-diamino-pyrimidin-5-yl-carboxamides as syk or jak kinases inhibitors
|
|
EP2271631B1
(en)
|
2008-04-22 |
2018-07-04 |
Portola Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
|
EP2280969A1
(en)
|
2008-04-29 |
2011-02-09 |
F. Hoffmann-La Roche AG |
Pyrimidinyl pyridone inhibitors of jnk.
|
|
PL2300013T5
(pl)
|
2008-05-21 |
2025-04-28 |
Takeda Pharmaceutical Company Limited |
Pochodne fosforu jako inhibitor kinazy
|
|
UY31929A
(es)
|
2008-06-25 |
2010-01-05 |
Irm Llc |
Compuestos y composiciones como inhibidores de cinasa
|
|
CA2986640C
(en)
|
2008-06-27 |
2019-03-26 |
Celgene Avilomics Research, Inc. |
Heteroaryl compounds and uses thereof
|
|
US8338439B2
(en)
|
2008-06-27 |
2012-12-25 |
Celgene Avilomics Research, Inc. |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
|
EP2325175A4
(en)
|
2008-09-01 |
2012-03-21 |
Astellas Pharma Inc |
2,4-DIAMINOPYRIMIDINVERBINDUNG
|
|
EP2159220A1
(en)
*
|
2008-09-02 |
2010-03-03 |
Nabriva Therapeutics AG |
Organic compounds
|
|
TWI453207B
(zh)
*
|
2008-09-08 |
2014-09-21 |
Signal Pharm Llc |
胺基三唑并吡啶，其組合物及使用其之治療方法
|
|
KR20110060894A
(ko)
|
2008-09-18 |
2011-06-08 |
아스테라스 세이야쿠 가부시키가이샤 |
복소환 카르복사미드 화합물
|
|
TW201016676A
(en)
|
2008-10-03 |
2010-05-01 |
Astrazeneca Ab |
Heterocyclic derivatives and methods of use thereof
|
|
CN102272291B
(zh)
|
2008-10-31 |
2018-01-16 |
詹森生物科技公司 |
人胚胎干细胞向胰腺内分泌谱系的分化
|
|
US8513242B2
(en)
|
2008-12-12 |
2013-08-20 |
Cystic Fibrosis Foundation Therapeutics, Inc. |
Pyrimidine compounds and methods of making and using same
|
|
JP5683489B2
(ja)
|
2009-01-12 |
2015-03-11 |
アレイ バイオファーマ、インコーポレイテッド |
ピペリジン含有化合物およびその用途
|
|
ES2433109T3
(es)
|
2009-01-13 |
2013-12-09 |
Glaxo Group Limited |
Derivados de pirimidin-carboxamida como inhibidores de la Syk cinasa
|
|
EP2389373B1
(en)
|
2009-01-21 |
2017-05-17 |
Rigel Pharmaceuticals, Inc. |
Derivatives of n2-(3-pyridyl or phenyl)-n4-(4-piperidyl)-2,4-pyrimidinediamine useful in the treatment of inflammatory, autoimmune or proliferative diseases
|
|
AR076550A1
(es)
|
2009-05-06 |
2011-06-22 |
Portola Pharm Inc |
Inhibidores de la janus tirosina kinasa (jak)
|
|
WO2010128659A1
(ja)
|
2009-05-08 |
2010-11-11 |
アステラス製薬株式会社 |
ジアミノへテロ環カルボキサミド化合物
|
|
JP2012148977A
(ja)
|
2009-05-20 |
2012-08-09 |
Astellas Pharma Inc |
アミノシクロヘキシルアルキル基を有する２，４−ジアミノピリミジン化合物
|
|
MX2011013325A
(es)
|
2009-06-10 |
2012-04-30 |
Abbott Lab |
2-(lh-pirazol-4-ilamino)-pirimidina como inhibidores de cinasa.
|
|
JP2012197231A
(ja)
|
2009-08-06 |
2012-10-18 |
Oncotherapy Science Ltd |
Ｔｔｋ阻害作用を有するピリジンおよびピリミジン誘導体
|
|
WO2011065800A2
(ko)
|
2009-11-30 |
2011-06-03 |
주식회사 오스코텍 |
피리미딘 유도체, 이의 제조방법 및 이를 함유하는 약학적 조성물
|
|
CA2780759A1
(en)
|
2009-12-01 |
2011-06-09 |
Rigel Pharmaceuticals, Inc. |
Protein kinase c inhibitors and uses thereof
|
|
EP2582671A4
(en)
*
|
2010-06-17 |
2014-02-26 |
Reddys Lab Ltd Dr |
PROCESS FOR PREPARING A SINGLE ENANTIOMER FROM 3-AMINOPIPERIDIN DIHYDROCHLORIDE
|
|
US8710223B2
(en)
|
2010-07-21 |
2014-04-29 |
Rigel Pharmaceuticals, Inc. |
Protein kinase C inhibitors and uses thereof
|
|
US8580805B2
(en)
|
2010-08-31 |
2013-11-12 |
Hubert Maehr |
Pyrimidine carboxamide derivatives
|
|
US20130244963A1
(en)
|
2010-09-30 |
2013-09-19 |
Portola Pharmaceuticals, Inc. |
Combination therapy with 4-(3-(2h-1,2,3-triazol-2-yl)phenylamino)-2-((1r,2s)-2-aminocyclohexylamino)pyrimidine-5-carboxamide
|
|
EP2621489A1
(en)
|
2010-09-30 |
2013-08-07 |
Portola Pharmaceuticals, Inc. |
Combinations of 4-(cyclopropylamino)-2-(4-(4-(ethylsulfonyl)piperazin-1-yl)phenylamino)pyrimidine-5-carboxamide and fludarabine
|
|
FI2699553T3
(fi)
*
|
2011-04-22 |
2024-01-24 |
Signal Pharm Llc |
Substituoituja diaminokarboksamidi- ja diaminokarbonitriilipyrimidiinejä, niiden koostumuksia ja niitä käyttäviä hoitomenetelmiä
|
|
WO2014019166A1
(zh)
*
|
2012-08-01 |
2014-02-06 |
上海威智医药科技有限公司 |
高活性硼烷类化合物的工业化生产方法
|
|
JP2014031327A
(ja)
*
|
2012-08-02 |
2014-02-20 |
Kaneka Corp |
光学活性シス−２−アミノ−シクロヘキサンカルボン酸誘導体およびその前駆体の製造法
|
|
RU2016129380A
(ru)
|
2013-12-20 |
2018-01-25 |
СИГНАЛ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи |
Замещенные диаминопиримидильные соединения, их композиции и способы лечения с их участием
|
|
NZ715903A
(en)
*
|
2014-01-30 |
2017-06-30 |
Signal Pharm Llc |
Solid forms of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use
|
|
TWI523838B
(zh)
*
|
2014-03-21 |
2016-03-01 |
Far Eastern New Century Corp |
Terephthalic acid and 4-methyl-3-cyclohexene-1-carboxylic acid Ester preparation method
|
|
ES2980464T3
(es)
|
2014-10-06 |
2024-10-01 |
Signal Pharm Llc |
Productos intermedios sintéticos útiles para preparar compuestos de aminopurina sustituidos
|
|
US9513297B2
(en)
|
2014-12-16 |
2016-12-06 |
Signal Pharmaceuticals, Llc |
Methods for measurement of inhibition of c-Jun N-terminal kinase in skin
|
|
KR102606253B1
(ko)
|
2014-12-16 |
2023-11-27 |
시그날 파마소티칼 엘엘씨 |
2-(tert-부틸아미노)-4-((1r,3r,4r)-3-하이드록시-4-메틸사이클로헥실아미노)-피리미딘-5-카복사마이드의 제형
|
|
WO2016123291A1
(en)
|
2015-01-29 |
2016-08-04 |
Signal Pharmaceuticals, Llc |
Isotopologues of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide
|
|
CA3208587A1
(en)
*
|
2015-07-24 |
2017-02-02 |
Celgene Corporation |
Methods of synthesis of (1r,2r,5r)-5-amino-2-methylcyclohexanol hydrochloride and intermediates useful therein
|